B-CELL MALIGNANCY
Clinical trials for B-CELL MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new B-CELL MALIGNANCY trials appear
Sign up with your email to follow new studies for B-CELL MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill shows promise for Hard-to-Treat blood cancers
Disease control Recruiting nowThis study tests an experimental oral drug, AS-1763, in adults with certain blood cancers (like CLL or lymphoma) that have not responded to at least two prior treatments. The main goals are to find the safest dose and see how well the drug controls the cancer. About 120 participa…
Matched conditions: B-CELL MALIGNANCY
Phase: PHASE1 • Sponsor: Carna Biosciences, Inc. • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New hope for hard-to-treat blood cancers: experimental combo therapy enters human trials
Disease control Recruiting nowThis study tests a new drug called BGB-16673, which breaks down a protein that helps cancer cells grow, combined with other treatments. It is for people with B-cell blood cancers (like certain lymphomas) that have returned or stopped responding to standard therapy. The goal is to…
Matched conditions: B-CELL MALIGNANCY
Phase: PHASE1, PHASE2 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New drug targets tough blood cancers in early trial
Disease control Recruiting nowThis study tests a new drug called BGB-16673 for people with certain B-cell blood cancers that have come back or not responded to other treatments. The drug works by breaking down a protein that helps cancer cells grow. The trial has two parts: first finding the best dose, then t…
Matched conditions: B-CELL MALIGNANCY
Phase: PHASE1, PHASE2 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC